Abstract
References
Articles referenced by this article (26)
Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits.
Acta Neuropathol, (4):419-424 2007
MED: 17639428
Inflamm-aging: autoimmunity, and the immune-risk phenotype.
Autoimmun Rev, (5):401-406 2004
MED: 15288008
Validating a screening questionnaire for parkinsonism in Australia
JNNP 2000
A population perspective on diagnostic criteria for Parkinson's disease.
Neurology, (5):1277-1281 1997
MED: 9153457
Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins.
J Neurochem, (6):2583-2589 2000
MED: 11080212
Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test.
Arch Neurol, (4):545-549 2003
MED: 12707068
Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease.
FASEB J, (3):419-425 2006
MED: 16507759
Is neuromelanin changed in Parkinson's disease? Investigations by magnetic spectroscopies.
J Neural Transm (Vienna), (6):769-774 2006
MED: 16755381
G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences.
Behav Res Methods, (2):175-191 2007
MED: 17695343
Ageing and Parkinson's disease: substantia nigra regional selectivity.
Brain, 2283-2301 1991
MED: 1933245
Show 10 more references (10 of 26)
Citations & impact
Impact metrics
Citations of article over time
Article citations
The immune system in Parkinson's disease: what we know so far.
Brain, 147(10):3306-3324, 01 Oct 2024
Cited by: 0 articles | PMID: 38833182 | PMCID: PMC11449148
Review Free full text in Europe PMC
Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond.
Curr Neuropharmacol, 22(6):1080-1109, 01 Jan 2024
Cited by: 1 article | PMID: 37898823 | PMCID: PMC10964103
Review Free full text in Europe PMC
Exploring the causal relationship between B lymphocytes and Parkinson's disease: a bidirectional, two-sample Mendelian randomization study.
Sci Rep, 14(1):2783, 02 Feb 2024
Cited by: 3 articles | PMID: 38307922 | PMCID: PMC10837417
Autoimmunity and Frontotemporal Lobar Degeneration: From Laboratory Study to Clinical Practice.
Clin Interv Aging, 18:495-503, 27 Mar 2023
Cited by: 1 article | PMID: 37008802 | PMCID: PMC10065017
Review Free full text in Europe PMC
Immune Regulatory Functions of Macrophages and Microglia in Central Nervous System Diseases.
Int J Mol Sci, 24(6):5925, 21 Mar 2023
Cited by: 6 articles | PMID: 36982999 | PMCID: PMC10059890
Review Free full text in Europe PMC
Go to all (43) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.
Neurosci Lett, 414(1):94-97, 29 Dec 2006
Cited by: 146 articles | PMID: 17196747
Humoral response to hsp 65 and hsp 70 in cerebrospinal fluid in Parkinson's disease.
J Neurol Sci, 139(1):66-70, 01 Jul 1996
Cited by: 19 articles | PMID: 8836974
Individual dopaminergic neurons show raised iron levels in Parkinson disease.
Neurology, 68(21):1820-1825, 01 May 2007
Cited by: 155 articles | PMID: 17515544
Neuromelanin-bound ferric iron as an experimental model of dopaminergic neurodegeneration in Parkinson's disease.
Parkinsonism Relat Disord, 14 Suppl 2:S185-8, 27 Jun 2008
Cited by: 15 articles | PMID: 18585086
Review